Research output per year
Research output per year
- 25 results
Search results
-
2024
The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancer
Derks, S. H. A. E., van der Meer, E. L., Joosse, A., de Jonge, M. J. A., Slagter, C., Schouten, J. W., Hoop, E. O. D., Smits, M., van den Bent, M. J., Jongen, J. L. M. & van der Veldt, A. A. M., 15 Sept 2024, In: International Journal of Cancer. 155, 6, p. 1045-1052 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
From decision to reflection: understanding the experiences and unmet care needs of patients treated with immunotherapy for melanoma in the adjuvant or metastatic setting
Kamminga, N. C. W., van der Veldt, A. A. M., Wakkee, M., van den Berge, F. R., van der Beek, L. A. A., Joosen, M. C. W., Joosse, A., de Joode, K., Nijsten, T. E. C. & Lugtenberg, M., 30 May 2024, In: BMC Cancer. 24, 1, 662.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Downloads (Pure) -
Comprehensive characterization of circulating tumor cells and cell-free DNA in patients with metastatic melanoma
Bos, M. K., Kraan, J., Starmans, M. P. A., Helmijr, J. C. A., Verschoor, N., De Jonge, M. J. A., Joosse, A., van der Veldt, A. A. M., te Boekhorst, P. A. W., Martens, J. W. M., Sleijfer, S. & Wilting, S. M., 24 May 2024, (E-pub ahead of print) In: Molecular Oncology.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Downloads (Pure) -
Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol
Janssen, J. C., van Dijk, B., de Joode, K., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Boers-Sonderen, M. J., van den Eertwegh, A. J. M., de Groot, J. W. B., Jalving, M., de Jonge, M. J. A., Joosse, A., Kapiteijn, E., Kamphuis-Huismans, A. M., Naipal, K. A. T., Piersma, D., Rikhof, B., Westgeest, H. M., Vreugdenhil, G. & Oomen-de Hoop, E. & 2 others, , 23 May 2024, In: BMC Cancer. 24, 1, 632.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Downloads (Pure) -
2023
Fecal Microbiota Transplantation for Immune Checkpoint Inhibitor-Induced Colitis Is Safe and Contributes to Recovery: Two Case Reports
Groenewegen, B., Terveer, E. M., Joosse, A., Barnhoorn, M. C. & Zwittink, R. D., 1 Jul 2023, In: Journal of Immunotherapy. 46, 6, p. 216-220 5 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile8 Citations (Scopus)54 Downloads (Pure) -
Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study
Kamminga, N. C. W., Wakkee, M., De Bruin, R. J., van der Veldt, A. A. M., Joosse, A., Reeder, S. W. I., Plaisier, P. W., Nijsten, T. & Lugtenberg, M., 28 Mar 2023, In: BMC Cancer. 23, 1, 11 p., 278.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)18 Downloads (Pure) -
Impact of Novel Treatments in Patients with Melanoma Brain Metastasis: Real-World Data
Derks, S. H. A. E., Jongen, J. L. M., van der Meer, E. L., Ho, L. S., Slagter, C., Joosse, A., de Jonge, M. J. A., Schouten, J. W., Oomen-de Hoop, E., van den Bent, M. J. & van der Veldt, A. A. M., 25 Feb 2023, In: Cancers. 15, 5, 1461.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Citations (Scopus)20 Downloads (Pure) -
Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report
de Joode, K., Veenbergen, S., Kransse, C., Kortleve, D., Debets, R., Mathijssen, R. H. J., Joosse, A., Schreurs, M. W. J. & Van der Veldt, A. A. M., 7 Feb 2023, In: Journal for ImmunoTherapy of Cancer. 11, 2, e006467.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Citations (Scopus)116 Downloads (Pure) -
2022
The meaning of screening: detection of brain metastasis in the adjuvant setting for stage III melanoma
Derks, S. H. A. E., de Joode, K., Mulder, E. E. A. P., Ho, L. S., Joosse, A., de Jonge, M. J. A., Verhoef, C., Grünhagen, D. J., Smits, M., van den Bent, M. J. & van der Veldt, A. A. M., 1 Dec 2022, In: ESMO Open. 7, 6, p. 100600 5 p., 100600.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Citations (Web of Science)78 Downloads (Pure) -
The course of C-peptide levels in patients developing diabetes during anti-PD-1 therapy
Basak, E. A., de Joode, K., Uyl, T. J. J., van der Wal, R., Schreurs, M. W. J., van den Berg, S. A. A., Oomen-de Hoop, E., van der Leest, C. H., Chaker, L., Feelders, R. A., van der Veldt, A. A. M., Joosse, A., Koolen, S. L. W., Aerts, J. G. J. V., Mathijssen, R. H. J. & Bins, S., Dec 2022, In: Biomedicine and Pharmacotherapy. 156, p. 113839 7 p., 113839.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Citations (Scopus)40 Downloads (Pure) -
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study
Basak, E. A., Vermeer, N. S., de Joode, K., Hurkmans, D. P., Velthuis, D. E. M., Oomen-de Hoop, E., Schreurs, M. W. J., Bins, S., Koolen, S. L. W., Debets, R., van der Veldt, A. A. M., Aerts, J. G. J. V., Joosse, A. & Mathijssen, R. H. J., Oct 2022, In: European Journal of Cancer. 174, p. 113-120 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile10 Citations (Scopus)72 Downloads (Pure) -
Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma
Kamminga, N. C. W., van der Veldt, A. A. M., Joosen, M. C. W., de Joode, K., Joosse, A., Grünhagen, D. J., Nijsten, T. E. C., Wakkee, M. & Lugtenberg, M., Sept 2022, In: British Journal of Dermatology. 187, 3, p. 381-391 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile16 Citations (Scopus)48 Downloads (Pure) -
2020
Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients
Basak, E., Meer, W., Hurkmans, D., Schreurs, M., Oomen - de Hoop, E., van der Veldt, A., Bins, S., Joosse, A., Koolen, S., Debets, R., Peeters, R., Aerts, J., Mathijssen, R. & Medici, M., Jul 2020, In: Thyroid. 30, 7, p. 966-973 8 p.Research output: Contribution to journal › Article › Academic › peer-review
59 Citations (Scopus) -
2019
Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment
Hurkmans, D. P., Verhoeven, J. G. H. P., De Leur, K., Boer, K., Joosse, A., Baan, C. C., Von Der Thüsen, J. H., Van Schaik, R. H. N., Mathijssen, R. H. J., Van Der Veldt, A. A. M. & Hesselink, D. A., 12 Jul 2019, In: Journal for ImmunoTherapy of Cancer. 7, 1, 182.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile27 Citations (Scopus)23 Downloads (Pure) -
2015
Sex Differences in Melanoma Survival are Not Related to Mitotic Rate of the Primary Tumor
Joosse, A., Ploeg, S., Haydu, L., Nijsten, T., Vries, E., Scolyer, R., Eggermont, A., Coebergh, J. W. & Thompson, J., 2015, In: Annals of Surgical Oncology. 22, 5, p. 1598-1603 6 p.Research output: Contribution to journal › Article › Academic › peer-review
20 Citations (Scopus) -
2014
Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study
Livingstone, E., Zandwijk - Hollestein, L., van Herk-Sukel, M., van de Poll-Franse, L., Joosse, A., Schilling, B., Nijsten, T., Schadendorf, D. & Vries, E., 2014, In: Cancer Medicine. 3, 5, p. 1284-1293 10 p.Research output: Contribution to journal › Article › Academic › peer-review
25 Citations (Scopus) -
2013
Sex Is an Independent Prognostic Indicator for Survival and Relapse/Progression-Free Survival in Metastasized Stage III to IV Melanoma: A Pooled Analysis of Five European Organisation for Research and Treatment of Cancer Randomized Controlled Trials
Joosse, A., Collette, S., Suciu, S., Nijsten, T., Patel, P., Keilholz, U., Eggermont, L., Coebergh, J. W. & Vries, E., 2013, In: Journal of Clinical Oncology. 31, 18, p. 2337-+Research output: Contribution to journal › Article › Academic › peer-review
142 Citations (Scopus) -
Sunny Holidays before and after Melanoma Diagnosis Are Respectively Associated with Lower Breslow Thickness and Lower Relapse Rates in Italy
Gandini, S., Vries, E., Tosti, G., Botteri, E., Spadola, G., Maisonneuve, P., Martinoli, C., Joosse, A., Ferrucci, P., Baldini, F., Cocorocchio, E., Pennacchioli, E., Cataldo, F., Bazolli, B., Clerici, A., Barberis, M., Bataille, V. & Testori, A., 2013, In: PLoS One (print). 8, 11Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile15 Citations (Scopus)11 Downloads (Pure) -
2012
Superior Outcome of Women With Stage I/II Cutaneous Melanoma: Pooled Analysis of Four European Organisation for Research and Treatment of Cancer Phase III Trials
Joosse, A., Collette, S., Suciu, S., Nijsten, T., Lejeune, F., Kleeberg, U., Coebergh, J. W., Eggermont, L. & Vries, E., 2012, In: Journal of Clinical Oncology. 30, 18, p. 2240-2247 8 p.Research output: Contribution to journal › Article › Academic › peer-review
147 Citations (Scopus) -
2011
Gender Differences in Melanoma Survival: Female Patients Have a Decreased Risk of Metastasis
Joosse, A., Vries, E., Eckel, R., Nijsten, T., Eggermont, L., Holzel, D., Coebergh, J. W. & Engel, J., 2011, In: Journal of Investigative Dermatology. 131, 3, p. 719-726 8 p.Research output: Contribution to journal › Article › Academic › peer-review
210 Citations (Scopus) -
2010
Extra attention for melanoma among elderly men
Vries, E., Joosse, A. & Coebergh, J. W., 2010, In: Nature Reviews Clinical Oncology. 7, 6Research output: Contribution to journal › Article › Academic › peer-review
2 Citations (Scopus) -
Reactive oxygen species and melanoma: an explanation for gender differences in survival?
Joosse, A., Vries, E., van Eijck, C., Eggermont, L., Nijsten, T. & Coebergh, J. W., 2010, In: Pigment Cell & Melanoma Research. 23, 3, p. 352-364 13 p.Research output: Contribution to journal › Article › Academic › peer-review
53 Citations (Scopus) -
2009
Does use of estrogens decrease Breslow thickness of melanoma of the skin?
van Hattem, S., Aarts, M., Louwman, W., Neumann, H., Coebergh, J. W., Looman, C., Koomen, E., Joosse, A., Herings, R., Casparie, M., Guchelaar, H. & Nijsten, T., 2009, In: Melanoma Research. 9, p. 327-332 6 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study
Koomen, E., Joosse, A., Herings, R., Casparie, M., Guchelaar, H. & Nijsten, T., 2009, In: Annals of Oncology. 20, 2, p. 358-364 7 p.Research output: Contribution to journal › Article › Academic › peer-review
73 Citations (Scopus) -
Non-Steroidal Anti-Inflammatory Drugs and Melanoma Risk: Large Dutch Population-Based Case-Control Study
Joosse, A., Koomen, E., Casparie, M., Herings, R., Guchelaar, H. & Nijsten, T., 2009, In: Journal of Investigative Dermatology. 129, 11, p. 2620-2627 8 p.Research output: Contribution to journal › Article › Academic › peer-review
38 Citations (Scopus)